Kebreten F. Manaye to Alzheimer Disease
This is a "connection" page, showing publications Kebreten F. Manaye has written about Alzheimer Disease.
Connection Strength
0.807
-
Manaye KF, Mouton PR, Xu G, Drew A, Lei DL, Sharma Y, Rebeck GW, Turner S. Age-related loss of noradrenergic neurons in the brains of triple transgenic mice. Age (Dordr). 2013 Feb; 35(1):139-47.
Score: 0.251
-
Kalifa S, Polston EK, Allard JS, Manaye KF. Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1?E9 double transgenic mice. Brain Res. 2011 Feb 28; 1376:94-100.
Score: 0.235
-
O'Neil JN, Mouton PR, Tizabi Y, Ottinger MA, Lei DL, Ingram DK, Manaye KF. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice. J Chem Neuroanat. 2007 Nov; 34(3-4):102-7.
Score: 0.184
-
LaClair KD, Manaye KF, Lee DL, Allard JS, Savonenko AV, Troncoso JC, Wong PC. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener. 2013 Jun 13; 8:18.
Score: 0.070
-
Brown D, Ramlochansingh C, Manaye KF, Tizabi Y. Nicotine promotes survival of cells expressing amyloid precursor protein and presenilin: implication for Alzheimer's disease. Neurosci Lett. 2013 Feb 22; 535:57-61.
Score: 0.068